Results of Outcome Measures in Rheumatology Clinical Trials (OMERACT) voting on domains to be included in clinical trials in psoriatic arthritis
| No | Item | Score |
|---|---|---|
| 1 | Joint activity | 99% |
| 2 | Patient global | 96% |
| All three components (total, joints, skin) | 76% | |
| 3 | Pain assessment | 94% |
| 4 | Physical function | 91% |
| 5 | Skin disease | 86% |
| 6 | Quality of life | 78% |
| 7 | Structural damage | 66% |
| 8 | Acute phase reactant | 64% |
| 9 | Axial involvement | 61% |
| 10 | Participation | 61% |
| 11 | Enthesitis | 60% |
| 12 | Fatigue | 48% |
| 13 | Dactylitis | 48% |
| 14 | Physician global | 41% |
| 15 | Tissue histology | 38% |
| 16 | Magnetic resonance imaging | 34% |
| 17 | Morning stiffness | 25% |
| 18 | Damaged joint count | 20% |